AKOS CZIBERE

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
AKOS CZIBERE's trades of Aktis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
461.00
Quantity 71,628 +47.1%
Value US$3,139,763
Transaction date
Sale
Price
261.36
Quantity 89,435 +26.0%
Value US$1,974,423
Transaction date
Sale
Price
420.68
Quantity 96,808 -49.4%
Value US$4,234,483
Transaction date
Proposed sale
Price
27.77
Quantity 50,000
Value US$1,388,700
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-08
S Sale
71,628 +47.1%
461.00
US$3,139,763 		71,628 +47.1% 461.00 US$3,139,763
2026-07-10 2026-07-08
S Sale
89,435 +26.0%
261.36
US$1,974,423 		89,435 +26.0% 261.36 US$1,974,423
2026-07-10 2026-07-08
S Sale
96,808 -49.4%
420.68
US$4,234,483 		96,808 -49.4% 420.68 US$4,234,483
2026-07-08 2026-07-08
PrS Proposed sale
50,000
27.77
US$1,388,700 		50,000 27.77 US$1,388,700